Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.
about
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down SyndromeIntracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).A cluster of protein kinases and phosphatases modulated in fetal Down syndrome (trisomy 21) brain.Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.
P2860
Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Gene dosage-dependent associat ...... tes of down syndrome patients.
@ast
Gene dosage-dependent associat ...... tes of down syndrome patients.
@en
type
label
Gene dosage-dependent associat ...... tes of down syndrome patients.
@ast
Gene dosage-dependent associat ...... tes of down syndrome patients.
@en
prefLabel
Gene dosage-dependent associat ...... tes of down syndrome patients.
@ast
Gene dosage-dependent associat ...... tes of down syndrome patients.
@en
P2093
P2860
P1476
Gene dosage-dependent associat ...... tes of down syndrome patients.
@en
P2093
Jerzy Wegiel
Karol Dowjat
Tatyana Adayev
Wojciech Kaczmarski
Yu-Wen Hwang
P2860
P304
P356
10.1097/NEN.0B013E31827733C8
P577
2012-12-01T00:00:00Z